But what if you could avoid getting COVID-19 altogether? That’s the potential promise of a new study on a drug made by ...

The man’s case didn’t give rise to any widespread variant, but it gave Gupta, with his HIV evolution background, the idea ...

Five years on, scientists are starting to understand how the virus can lead to long-term, sometimes invisible changes.

Scientists reveal that reactivation of Epstein-Barr virus (EBV), driven by TGFβ-induced immune suppression, is a key driver ...

In a study published in the journal, Cell, Jing Chen, PhD, and colleagues at the Wuhan Institute of Virology, Wuhan, China, ...

New findings add weight to the theory that COVID-19 originated at the Wuhan Institute of Virology. Experts point to lax ...

The antibodies attach to a part of the virus that doesn't appear to mutate, potentially allowing them to work on multiple ...

New research reveals that Epstein-Barr virus reactivation, triggered by COVID, may cause MIS-C in children. MIS-C is a severe ...

University of Virginia School of Medicine scientists have discovered how severe COVID-19 can destroy immune cells' ability to ...

Research identifies how viral respiratory infection damages macrophages and suggests treatment with a pre-existing FDA approved drug.

MIS-C is a serious inflammatory shock that affects children. It can occur several weeks after a COVID infection and can be ...

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...